PRIVATE CAPITAL MANAGEMENT LLC - AMPIO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
PRIVATE CAPITAL MANAGEMENT LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$57,000
-87.1%
937,2370.0%0.02%
-85.0%
Q2 2022$441,0000.0%937,2370.0%0.14%0.0%
Q1 2022$441,000
-17.4%
937,2370.0%0.14%
-23.9%
Q4 2021$534,000
-65.7%
937,2370.0%0.18%
-71.1%
Q3 2021$1,556,000
-0.6%
937,2370.0%0.64%
-11.2%
Q2 2021$1,565,000
-1.2%
937,2370.0%0.72%
-14.5%
Q1 2021$1,584,000
+14.2%
937,2370.0%0.84%
+1.7%
Q4 2020$1,387,000
-10.1%
937,237
-22.5%
0.82%
+41.3%
Q2 2020$1,542,000
+469.0%
1,209,770
+85.0%
0.58%
+136.4%
Q1 2020$271,000
-17.4%
654,0770.0%0.25%
+8.3%
Q4 2019$328,0000.0%654,0770.0%0.23%
+0.4%
Q3 2019$328,000654,0770.23%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Cypress Capital Management LLC (WY) 234,225$132,0000.18%
Noven Financial Group, Inc. 123,772$70,0000.04%
Harvest Investment Services, LLC 109,443$60,0000.04%
GSA CAPITAL PARTNERS LLP 559,489$314,0000.03%
COURIER CAPITAL LLC 354,973$199,0000.03%
Valeo Financial Advisors, LLC 330,000$185,0000.02%
Transform Wealth, LLC 205,481$115,0000.02%
WEDBUSH SECURITIES INC 326,793$184,0000.02%
STEEL GROVE CAPITAL ADVISORS, LLC 55,500$31,0000.02%
MONTAG A & ASSOCIATES INC 230,000$129,0000.01%
View complete list of AMPIO PHARMACEUTICALS INC shareholders